Skip to content

Wearable Monitoring Device in Daily Lives of Community-dwelling Older Adults

Optimizing the Health-related Functions of a Wearable Monitoring Device in the Daily Life of Community-dwelling Older Adults: A Randomized Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05269303
Enrollment
72
Registered
2022-03-07
Start date
2022-07-10
Completion date
2023-07-09
Last updated
2023-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Device Ineffective

Keywords

community-dwelling older adults, Wearable monitoring device

Brief summary

The aim is to implement an intervention program to promote the continued use of Wearable Monitoring Devices among older adults through a peer support approach facilitating the incorporation of Wearable Monitoring Devices in daily life.

Interventions

DEVICELive With Wearable Monitoring Device program

The participants in the intervention group will receive a home visit by a Community Healthcare Worker in the first month, and biweekly motivational messages via Whats App in the second and third months.

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* aged 60 or above * own a smartphone * able to communicate in Cantonese or Mandarin * able to access the Internet at home or elsewhere

Exclusion criteria

* have a confirmed diagnosis of cognitive impairment * bed-bound * currently own a wearable monitoring device * have already engaged in other wearable device studies

Design outcomes

Primary

MeasureTime frameDescription
The change of use intention of wearable monitoring deviceData collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time pointsIt will be measured using a 4-item, 5-point Likert scale adopted from Bhattacherjee (2001) and Windasari et al. (2021). The five-point scale ranges from 1 = not at all satisfied to 5 = very certain, with higher scores representing a higher chance of continuing to use the WMD.

Secondary

MeasureTime frameDescription
The change in quality of life among baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time pointsbaseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time pointsQuality of life will be measured using the Hong Kong version of the EuroQol 5-dimension scale. The EQ-5D-5L is comprised of five dimensions, namely, mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. The utility score ranges from 0 to 1, with higher means better quality of life
The change of health service utilization among baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time pointsbaseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time pointsealth service utilization includes the number of attendances at a general practitioner's office, emergency department, hospital, and general out-patient clinic. The data will be reported by the participants and confirmed with medical and attendance certificates
Recruitment ratebaseline pre-interventionThe recruitment rate will be calculated by dividing the number of participants who are recruited and randomized, by the number of eligible participants.
The change of adherence rate of wearing wearable monitoring deviceData collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time pointsIt will be measured by checking in our database the number of days that participants wore their device, and the average amount of time worn per day. Longer time worn represents better adherence rate
Incidence of reports of adverse events6-month (T3) time pointsthe incidence of reports of adverse events will be recorded by a staff member assigned to each of the community centres and a nurse
Incidence of reports of technical difficulties6-month (T3) time pointsIncidence of reports of technical difficulties will be recorded by a staff member assigned to each of the community centres and a nurse
The change of perceived usability of the wearable monitoring device before and after the programbaseline pre-intervention, 6-month (T3) time pointsThe participants will be required to complete a questionnaire that measures their attitude towards using the WMD; the perceived usefulness, perceived ease of use, and self-efficacy of using the device; and their level of anxiety about using the device. The questionnaire was drawn up by Chen and Chan (2014). This 10-point Likert scale ranges from 1 (strongly disagree) to 10 (strongly agree), with higher marks indicating a better outcome, with the exception of the item on anxiety levels, where higher marks represent a higher level of anxiety in using the WMD.
Attrition rate6-month (T3) time pointsThe attrition rate refers to the number of participants who withdraw from the study or who are lost to follow up.

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026